Education
About Us
Working with TipRanks
Follow Us
Microbot Medical Inc (MBOT)
NASDAQ:MBOT
MBOT Stock Chart & Stats
$2.15
-$1.10(-38.87%)
At close: 4:00 PM EST
$2.15
-$1.10(-38.87%)
Day’s Range― - ―
52-Week Range$1.25 - $4.67
Previous CloseN/A
Volume6.51M
Average Volume (3M)5.97M
Market Cap
$144.39M
Enterprise Value$0.00
Total Cash (Recent Filing)$80.16M
Total Debt (Recent Filing)$899.00K
Price to Earnings (P/E)―
Beta1.74
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding67,158,040
10 Day Avg. Volume3,110,764
30 Day Avg. Volume5,974,630
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)4.96
Price to Sales (P/S)0.00
P/FCF Ratio-1.98
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$8.75Price Target Upside306.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Commercial Rollout And Hospital AdoptionLimited market release with initial adoption by a major hospital validates clinical interest and creates a foundation of real-world evidence to support broader hospital sales and referral adoption.
Regulatory ApprovalFDA clearance for the LIBERTY system as the first approved single-use remote robotic platform for peripheral endovascular procedures positions the company as an early leader and reduces regulatory uncertainty for commercial sales.
Reimbursement And Go-to-market StrategyExisting reimbursement codes for complex peripheral procedures, combined with available capital and an aggressive pricing approach, increases the likelihood of hospital adoption and scalable revenue generation.
Bears Say
Commercialization And Expansion RiskDelays in broader commercialization or inability to expand the technology into cardiac and neuro procedures would materially limit revenue opportunities and undermine the investment thesis.
Market Penetration And CompetitionSlower-than-expected uptake due to limited addressable market, low penetration rates, or competing technologies could constrain growth and reduce the potential market share.
Profitability And Financial RiskSustained lack of profitability driven by launch costs and single-use device economics could pressure cash flow and investor confidence before the business reaches scale.
Microbot Medical News
MBOT FAQ
What was Microbot Medical Inc’s price range in the past 12 months?
Microbot Medical Inc lowest stock price was $1.25 and its highest was $4.67 in the past 12 months.
What is Microbot Medical Inc’s market cap?
Microbot Medical Inc’s market cap is $144.39M.
When is Microbot Medical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Microbot Medical Inc’s earnings last quarter?
Currently, no data Available
Is Microbot Medical Inc overvalued?
According to Wall Street analysts Microbot Medical Inc’s price is currently Undervalued.
Does Microbot Medical Inc pay dividends?
Microbot Medical Inc does not currently pay dividends.
What is Microbot Medical Inc’s EPS estimate?
Microbot Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microbot Medical Inc have?
Microbot Medical Inc has 67,158,040 shares outstanding.
What happened to Microbot Medical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Microbot Medical Inc?
Currently, no hedge funds are holding shares in MBOT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Microbot Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Price Target Potential
299.54% Upside
Analyst Consensus
Moderate Buy
Average Price Target:
$8.75 (306.98% Upside)
$8.75 (306.98% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.5%
Last 30 Days ▼ 7.0%
Last 30 Days ▼ 7.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
186.01%
12-Months-Change
Fundamentals
Return on Equity
-69.80%
Trailing 12-Months
Asset Growth
345.67%
Trailing 12-Months
Company Description
Microbot Medical Inc
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
MBOT Stock 12 Month Forecast
Average Price Target
$8.75
▲(306.98% Upside)
Technical Analysis
Ownership Overview
0.20%
Insiders
3.79% Mutual Funds
3.84% Other Institutional Investors
88.71% Public Companies and
Individual Investors